Strensiq 25682-0016-12
Generic: Asfotase Alfa
- Manufacturer
- Alexion Pharmaceuticals, Inc.
- Dosage Form
- Solution
- Route
- Subcutaneous
- Product Type
- Human Prescription Drug
- Marketing Start
- October 23, 2015
- Listing Expires
- December 31, 2026
- Application
- BLA125513
Need to source Strensiq? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Asfotase Alfa | 40 mg/mL |
Drug Class
Tissue-nonspecific Alkaline Phosphatase [EPC]Alkaline Phosphatase [CS]Tissue-nonspecific Alkaline Phosphatase [EPC]
Selected Package
25682-0016-12Selected12 VIAL in 1 CARTON (25682-016-12) / 1 mL in 1 VIAL (25682-016-01)